- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
M. Alexander Koch (Alec)
Events 9 results
Speaking Engagement
November 17, 2022
M. Alexander Koch to Speak on Forensics EY Webcast
Speaking Engagement
November 15, 2022
Alec Koch to Speak at Securities Enforcement Forum 2022
Conference
November 1, 2022
Pharmaceutical University 2022
Speaking Engagement
September 21, 2022
Alec Koch to Speak at EY’s Americas Forensics Symposium 2022
Speaking Engagement
September 19, 2022
Alec Koch to Speak at Practising Law Institute’s Hedge Fund and Private Equity Enforcement & Regulatory Developments 2022 Event
Speaking Engagement
April 22, 2022
Alexander Koch to Speak on Ethics & Compliance Initiative’s Impact 2022 Event
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
May 31, 2017
ClinicalTrials.gov – Navigating the New Rule and the Expansion of Public Disclosure of Your Clinical Trial Data
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University